Abbott India Ltd.

26,280

215 (0.8%)stock indicator image for upward trend

ABBOTINDIA Share Price
As on June 12, 2026
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
Basic IndustryPharmaceuticals
Market Cap55,931 Cr
P/E Ratio39.48
Dividend Yield0.18 %
Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

This image for unlock stock of the monthUnlock Stock of the Month

T&C*

Company Information


Market Insights
Open26,195
High26,435
NSE SymbolABBOTINDIA
Close26,280
Low25,960
BSE Symbol500488
Previous Years High/Low
1 Year High37,000
3 Year High37,000
5 Year High37,000
1 Year Low25,150
3 Year Low21,919.6
5 Year Low15,514

Technicals


IndicatorsValueSignal
5-DMA26,137Bullish
10-DMA26,196.5Bullish
20-DMA26,926Bearish
50-DMA26,361.3Bearish
100-DMA26,653.25Bearish
200-DMA28,186.35Bearish

Historical Performance


1 Year
-16.8%
3 Years
19.7%
5 Years
61%
10 Years
490.6%

Shareholding Pattern


%

Values Analysis


Loading chart...

Profit & Loss

Below figures are in Rs. Crores


ParticularsNov-2001
Net Sales3,563
Total Expenditure3,059
Other Income205
Operating Profit709
Interest1
Depreciation45
Profit Before Tax663
Consolidated Net Profit497
Adjusted EPS31
Compounded Sales Growth
10 Years:22.9
5 Years:9.4
3 Years:5.5
TTM:1.8
Compounded Profit Growth
10 Years:43.9
5 Years:19
3 Years:12.1
TTM:3.3
Stock Price CAGR
10 Years:19.4
5 Years:10
3 Years:5.9
TTM:-16.6
Return on Equity
10 Years:120.1
5 Years:325
3 Years:446.8
last year:665.6

Quarterly Results

Below figures are in Rs. Crores


ParticularsSep-2024Dec-2024Mar-2025Jul-2025Sep-2025
Sales1,70,7541,35,9361,28,5521,22,1891,05,161
Expenses63,04256,55752,45745,45934,856
Operating Profit1,07,71279,37976,09676,73070,304
OPM %63%58%59%63%67%
Other Income33,91231,75927,33324,87918,947
Interest77,78058,58459,24862,13753,713
Depreciation2,3451,6811,3851,2771,221
Profit Before Tax61,49850,87342,79638,19534,318
Tax %25%25%26%29%35%
Net Profit46,14938,15131,85727,29622,446
EPS in Rs8369585042

Balance Sheet

Below figures are in Rs. Crores


0%
Positive
(80 to 100)
Neutral
(60 to 79)
Negative
(0 to 59)
  • The stock has a high PE of 39.48, indicating expensive valuation or elevated growth expectations.
  • Over the last three years, the stock delivered a moderate 3-year price CAGR of 5.9%, reflecting average market performance.
  • The stock carries a low beta of 0.4, suggesting lower volatility than the broader market.
  • In the last financial year, the company reported an EBITDA of ₹19702 million, reflecting positive operating performance.
  • In the previous financial year, the company generated revenue of ₹64091 million, indicating a large and established business.

Investment Calculator


Investment Amount: ₹ 1000000
Current Value: ₹ 833888.6
No. of Shares: 32 (Approx)
Performance:-16.6%
P/L: ₹-166111.4
NIFTY Performance: -4.4%
1 day Top Gainers
SymbolChange%
IFCI84.57(20%)
AIIL530.15(15%)
TTML46.44(10%)
ASHOKLEY152.45(10%)
NETWEB4587.4(9%)
1 Day Top Losers
SymbolChange%
NESTLEIND1375.7(-3%)
OIL417.8(-3%)
ONGC246.2(-3%)
TECHM1429.2(-3%)
ONESOURCE1612.5(-2%)
INOXINDIA1808.2(-2%)
PREMIERENE1034.6(-2%)
IPCALAB1583(-2%)

Top Performing Stocks from the same sector


Venus Remedies Ltd.

92.9%

1797.5

1 Month Performance

Bliss GVS Pharma Ltd.

59.9%

437.85

1 Month Performance

Panacea Biotec Ltd.

46.6%

536

1 Month Performance

Sakar Healthcare Ltd.

44.7%

824.1

1 Month Performance

Supriya Lifescience Ltd.

44.6%

977.15

1 Month Performance

Rubicon Research Ltd.

39.6%

1295.5

1 Month Performance

NGL Fine-Chem Ltd.

39.3%

3048.8

1 Month Performance

Senores Pharmaceuticals Ltd.

38.3%

1290

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month